Abstract

There is an extensive literature showing that R&D intensities and increases are positively related to firm performance, but there is little research on the valuation of R&D reductions. This paper contributes to the literature by examining the long-term performance following significant R&D reductions. We find that, contrary to conventional wisdom, large R&D cuts are associated with significantly positive future stock returns. This return drift cannot be explained by a battery of important factors in asset pricing nor properly accounted for by R&D intensity or prior R&D increases. We explore two potential economic motives behind R&D reductions—R&D spillover and firm life cycle. We show that operating performance deteriorates immediately before R&D reductions but exhibits no abnormal pattern afterward, evidence inconsistent with the spillover hypothesis. While firm growth falls substantially and variability in profitability reduces, firms with low or declining investment opportunities outperform. These findings lend support to a firm life cycle story that firms attempt to resolve the overinvestment problem that arises as they move to a lower growth stage. We further show a significant decline in the cost of capital after R&D reductions, but the market appears to underestimate the improvement in the cost of capital.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.